Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» congenital adrenal hyperplasia
congenital adrenal hyperplasia
Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win
Fierce Biotech
Tue, 09/12/23 - 10:47 am
Neurocrine Biosciences
crinecerfont
clinical trials
congenital adrenal hyperplasia
Spruce's Drug Candidate Reduces Elevated Hormones in Classic CAH Patients
BioSpace
Tue, 06/22/21 - 10:32 pm
Spruce Biosciences
clinical trials
congenital adrenal hyperplasia
tildacerfont
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug
Xconomy
Sat, 02/22/20 - 11:34 pm
Spruce Biosciences
congenital adrenal hyperplasia
Armed with a batch of positive biomarker data, a rare disease player reaps $88M for the next big push in the clinic
Endpoints
Thu, 02/20/20 - 10:28 am
Spruce
tildacerfont
congenital adrenal hyperplasia
Neurocrine hits the brakes on its genetic disease drug
Fierce Biotech
Tue, 06/9/15 - 10:16 am
Neurocrine
NBI-77860
congenital adrenal hyperplasia